Hydrochloric Acid → Tert-butyl 4-[3-(propylamino)pyridin-2-yl]piperazine-1-carboxylate
反応式
C([BH3-])#N.[Na+].[CH3:5][C:6]([CH3:24])([O:8][C:9]([N:11]1[CH2:16][CH2:15][N:14]([C:17]2[C:22]([NH2:23])=[CH:21][CH:20]=[CH:19][N:18]=2)[CH2:13][CH2:12]1)=[O:10])[CH3:7].[CH3:25][CH2:26][CH:27]=O.Cl.[OH-].[NH4+]>ClCCl.CO>[CH3:7][C:6]([CH3:24])([O:8][C:9]([N:11]1[CH2:12][CH2:13][N:14]([C:17]2[C:22]([NH:23][CH2:25][CH2:26][CH3:27])=[CH:21][CH:20]=[CH:19][N:18]=2)[CH2:15][CH2:16]1)=[O:10])[CH3:5]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
Sodium cyanoborohydride (0.31 g) is added to a cold solution of 1-[1,1-dimethylethoxycarbonyl]-4-[3-amino-2-pyridinyl]piperazine (International Publication No. WO 88/08424, 2.8 g), propional (0.87 g), and methanol (15 ml). After the exotherm has subsided, the reaction is stirred at 20°-25° overnight. The reaction is acidified (pH 2) with aqueous hydrochloride and then diluted with dichloromethane. The pH is adjusted with aqueous ammonium hydroxide (pH 8), and the phases are separated. The organic phase is dried over sodium sulfate, and concentrated under reduced pressure to a crude product which is dissolved in diethyl ether and allowed to crystallize at -5°. The solid is identified as starting material. The mother liquor is concentrated in vacuo to give the title compound.
後処理
- customthe phases are separated
- dry with materialThe organic phase is dried over sodium sulfate
- concentrationconcentrated under reduced pressure to a crude product which
- dissolutionis dissolved in diethyl ether
- customto crystallize at -5°
- concentrationThe mother liquor is concentrated in vacuo
出典と根拠
- ORDレコード
- ord-926554b64255408cad90e3f7eebe43c5
- 出典データセット
- uspto-grants-1996_02
- 特許番号
- US05489593
反応ノート
読み込み中…